Botox Adds Therapeutic Indication For Idiopathic Overactive Bladder
This article was originally published in The Pink Sheet Daily
Executive Summary
The FDA approval for idiopathic OAB follows a narrower indication for OAB related to neurological diseases such as multiple sclerosis or spinal cord injury.